Literature DB >> 27832426

Long-Term Outcomes in Indeterminate Colitis Patients Undergoing Ileal Pouch-Anal Anastomosis: Function, Quality of Life, and Complications.

Katharine L Jackson1, Luca Stocchi2, Leonardo Duraes2, Ahmet Rencuzogullari2, Ana E Bennett3, Feza H Remzi2.   

Abstract

INTRODUCTION: It is uncertain whether the outcomes of patients with indeterminate colitis (IC) undergoing ileal pouch-anal anastomosis (IPAA) deteriorate over time. The aim of this study was to determine the long-term pouch function, quality of life, complications, and incidence of Crohn's disease after IPAA for patients with IC compared to ulcerative colitis (UC).
METHODS: A case matched analysis was performed on patients undergoing IPAA for pathologically confirmed IC or UC, between 1985 and 2014. Patients were case matched for age ± 5 years, gender, date of surgery ± 3 years, type of anastomosis and presence of a diverting loop ileostomy. All patients were followed up for greater than six months.
RESULTS: 448 patients were case matched, the average age was 36.8 year old and 52.7 % of patients were male. Mean follow-up was 122.06 months (+/- 80.77 months). There were statistically and clinically comparable number of daytime bowel movements (5.7 v 5.5, p = 0.45), rates of incontinence (26.1 % v 18.3 %, p = 0.09) and nighttime seepage in patients (23.1 % v 28.4 %, p = 0.28) with IC and UC. Quality of life markers and patient restrictions were comparable between the two groups. Rates of pelvic sepsis (IC 8.5 %, UC 8.5 %, p = 0.99) and anastomotic leak (IC 3.1 %, UC 4.0 %, p = 0.61) were similar but fistula formation (IC 15.6 %, UC 8.0 %, p = 0.01) and IPAA Crohn's disease rates (IC 6.7 %, UC 2.7 %, p = 0.04) were significantly increased in IC patients. There was no statistically significant difference in pouch failure rates for IC and UC (5.8 % vs.4.9 %, p = 0.58).
CONCLUSION: Patients undergoing IPAA for IC have a higher risk of post-operative fistulae and development of Crohn's disease, but comparable morbidity, functional outcomes, quality of life scores and pouch failure rates when compared to UC patients. Long-term data confirms that IPAA is a good surgical option in patients with IC.

Entities:  

Keywords:  Ileal pouch-anal anastomosis; Indeterminate colitis; Outcomes; Quality of life; Restorative proctocolectomy

Mesh:

Year:  2016        PMID: 27832426     DOI: 10.1007/s11605-016-3306-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  16 in total

1.  Indeterminate colitis: the real story.

Authors:  William G Rudolph; Sonja M S Uthoff; Tracy L McAuliffe; Elizabeth T Goode; Robert E Petras; Susan Galandiuk
Journal:  Dis Colon Rectum       Date:  2002-11       Impact factor: 4.585

2.  Crohn's disease and indeterminate colitis and the ileal pouch-anal anastomosis: outcomes and patterns of failure.

Authors:  Carl J Brown; Anthony R Maclean; Zane Cohen; Helen M Macrae; Brenda I O'Connor; Robin S McLeod
Journal:  Dis Colon Rectum       Date:  2005-08       Impact factor: 4.585

3.  Overlap in the spectrum of non-specific inflammatory bowel disease--'colitis indeterminate'.

Authors:  A B Price
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

4.  Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients.

Authors:  Victor Warren Fazio; Ravi P Kiran; Feza H Remzi; John Calvin Coffey; Helen Mary Heneghan; Hasan Tarik Kirat; Elena Manilich; Bo Shen; Sean T Martin
Journal:  Ann Surg       Date:  2013-04       Impact factor: 12.969

5.  Long-term outcomes of restorative proctocolectomy for Crohn's disease and indeterminate colitis.

Authors:  P P Tekkis; A G Heriot; O Smith; J J Smith; A C J Windsor; R J Nicholls
Journal:  Colorectal Dis       Date:  2005-05       Impact factor: 3.788

6.  Equivalent function, quality of life and pouch survival rates after ileal pouch-anal anastomosis for indeterminate and ulcerative colitis.

Authors:  Conor P Delaney; Feza H Remzi; Terry Gramlich; Babak Dadvand; Victor W Fazio
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

7.  Operative strategy modifies risk of pouch-related outcomes in patients with ulcerative colitis on preoperative anti-tumor necrosis factor-α therapy.

Authors:  Jinyu Gu; Feza H Remzi; Bo Shen; Jon D Vogel; Ravi P Kiran
Journal:  Dis Colon Rectum       Date:  2013-11       Impact factor: 4.585

8.  Indeterminate colitis predisposes to perineal complications after ileal pouch-anal anastomosis.

Authors:  W A Koltun; D J Schoetz; P L Roberts; J J Murray; J A Coller; M C Veidenheimer
Journal:  Dis Colon Rectum       Date:  1991-10       Impact factor: 4.585

9.  Long-term outcomes with ileal pouch-anal anastomosis and Crohn's disease: pouch retention and implications of delayed diagnosis.

Authors:  Genevieve B Melton; Victor W Fazio; Ravi P Kiran; Jin He; Ian C Lavery; Bo Shen; Jean-Paul Achkar; James M Church; Feza H Remzi
Journal:  Ann Surg       Date:  2008-10       Impact factor: 12.969

10.  The fate of the ileal pouch in patients developing Crohn's disease.

Authors:  Joshua M Braveman; David J Schoetz; Peter W Marcello; Patricia L Roberts; John A Coller; John J Murray; Lawrence C Rusin
Journal:  Dis Colon Rectum       Date:  2004-10       Impact factor: 4.585

View more
  6 in total

1.  Case-Matched Comparison of Long-Term Functional and Quality of Life Outcomes Following Laparoscopic Versus Open Ileal Pouch-Anal Anastomosis.

Authors:  Olga A Lavryk; Luca Stocchi; Jean H Ashburn; Meagan Costedio; Emre Gorgun; Tracy L Hull; Hermann Kessler; Conor P Delaney
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

Review 2.  Is There a Role for Ileal Pouch Anal Anastomosis in Crohn's Disease?

Authors:  Nicole E Lopez; Karen Zaghyian; Phillip Fleshner
Journal:  Clin Colon Rectal Surg       Date:  2019-06-17

3.  When Not to Pouch: Important Considerations for Patient Selection for Ileal Pouch-Anal Anastomosis.

Authors:  Shannon Chang; Bo Shen; Feza Remzi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-08

4.  Bowel Function After J-Pouch May Be More Complex Than Previously Appreciated: A Comprehensive Analysis to Highlight Existing Knowledge Gaps.

Authors:  Grace C Lee; Paul M Cavallaro; Lieba R Savitt; Richard A Hodin; Hiroko Kunitake; Rocco Ricciardi; Liliana G Bordeianou
Journal:  Dis Colon Rectum       Date:  2020-02       Impact factor: 4.412

5.  Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.

Authors:  Amanda D Williams; Olga Y Korolkova; Amos M Sakwe; Timothy M Geiger; Samuel D James; Roberta L Muldoon; Alan J Herline; J Shawn Goodwin; Michael G Izban; Mary K Washington; Duane T Smoot; Billy R Ballard; Maria Gazouli; Amosy E M'Koma
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

6.  Prevalence of 'pouch failure' of the ileoanal pouch in ulcerative colitis: a systematic review and meta-analysis.

Authors:  Zaid Alsafi; Alice Snell; Jonathan P Segal
Journal:  Int J Colorectal Dis       Date:  2021-11-26       Impact factor: 2.571

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.